Phase 2 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are biologically male or female, aged 18 to 99 years
- People who have been diagnosed with a skin cancer (such as cutaneous melanoma, Merkel cell carcinoma, squamous cell carcinoma, or another type of skin cancer) confirmed by a tissue sample, and for whom a doctor has recommended a procedure to check nearby lymph nodes (called lymphoscintigraphy and sentinel lymph node biopsy)
Who may not be able to join:
- People with a known allergy or bad reaction to numbing creams or medicines such as EMLA cream, lidocaine, prilocaine, or similar local anaesthetics
- People with a history of allergy to adhesive materials (such as bandages or medical tape)
- People for whom the use of a radioactive tracer injection (Tc99) used during the lymph node mapping procedure is medically unsuitable (confirm with trial site)
- People who are currently incarcerated
- People who are not able to give their own consent independently
- People whose lymph node mapping procedure site is in a mucosal or genital area
- People who are pregnant
- People who have chronic pain listed as an existing diagnosis in their own declaration or in their Ohio State University medical records
- People who have pain lasting 3 months or longer (as defined by the US Centers for Disease Control and Prevention), unless their pain is from a stable condition such as nerve damage, fibromyalgia, arthritis, or cancer-related pain and they do not use narcotic (opioid) pain medicines
- People who have used narcotic (opioid) pain medicines at any point in the 7 days before the procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carlo M Contreras, MD, Ohio State University Comprehensive Cancer Center
Phone: 800-293-5066
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pain score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.